(Q45384943)

14 December 2017

title

Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep (English)

1 reference

14 December 2017

0 references

6

1 reference

14 December 2017

1

Michael Eschbaumer

0 references

Jörn Gethmann

object named as

Jörn M Gethmann

5

0 references

Thomas Mettenleiter

8

object named as

Thomas C Mettenleiter

1 reference

14 December 2017

9

Martin Beer

1 reference

14 December 2017

Bernd Hoffmann

2

1 reference

14 December 2017

Patricia König

3

1 reference

14 December 2017

Jens P Teifke

4

1 reference

14 December 2017

Carolina Probst

7

1 reference

14 December 2017

language of work or name

English

0 references

publication date

9 May 2009

1 reference

14 December 2017

1 reference

14 December 2017

volume

27

1 reference

14 December 2017

issue

31

1 reference

14 December 2017

page(s)

4169-4175

1 reference

Bluetongue virus: virology, pathogenesis and immunity

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Bluetongue in Europe: vectors, epidemiology and climate change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Bluetongue Epidemiology in the European Union

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Bluetongue virus serotype 8 reemergence in Germany, 2007 and 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Epidemiology of bluetongue virus serotype 8, Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Possible routes of introduction of bluetongue virus serotype 8 into the epicentre of the 2006 epidemic in north-western Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Vaccines against bluetongue in Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Bluetongue vaccines: the past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Live attenuated bluetongue vaccine viruses in Dorset Poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Regulatory issues surrounding the temporary authorisation of animal vaccination in emergency situations: the example of bluetongue in Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Animal disease. Exotic disease of farm animals tests Europe's responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Bluetongue virus: European Community inter-laboratory comparison tests to evaluate ELISA and RT-PCR detection methods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Experimental reproduction of severe bluetongue in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Immune responses and protective efficacy of binary ethylenimine (BEI)-inactivated bluetongue virus vaccines in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

An experimental inactivated vaccine against bluetongue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Antibody responses to human erythrocytes and ovalbumin as marker traits of disease resistance in dairy calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Susceptibility of Culicoides variipennis sonorensis to infection by polymerase chain reaction-detectable bluetongue virus in cattle blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Duration of viraemia infectious to Culicoides sonorensis in bluetongue virus-infected cattle and sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Isolation and identification of bluetongue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

Clinical signs and pathology shown by British sheep and cattle infected with bluetongue virus serotype 8 derived from the 2006 outbreak in northern Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.056

10.1016/J.VACCINE.2009.04.056

7 January 2021

Identifiers

DOI

1 reference

14 December 2017

1 reference